Brief: Cleveland Biolabs, On Aug 6, Entered License Agreement With Genome Protection
10/08/2018 22:25
Aug 10 (Reuters) - Cleveland Biolabs Inc CBLI.O :
* CLEVELAND BIOLABS - ON AUG 6, CO ENTERED LICENSE AGREEMENT
WITH
GENOME PROTECTION
* CLEVELAND BIOLABS INC - ENTERED INTO AN ASSIGNMENT
AGREEMENT
WITH GPI, DATED AS OF AUGUST 6, 2018
Source text (https://bit.ly/2MjA7eE)
Further company coverage: CBLI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Statera Biopharma
See all news20/20 Biolabs jumps on Ebola, hantavirus testing plans
Tivic Health Systems rises after deal for late-stage immunotherapy drug
Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist
Brief: Statera Biopharma Inc Quarterly Loss Per Share $0.20
Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc